Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)

10.1186/1748-717X-4-23

Saved in:

Bibliographic Details
Main Authors:	Loong, S.L.E, Hwang, J.S.G, Li, H.H, Wee, J.T.S, Yap, S.P, Chua, M.L.K, Fong, K.W, Tan, T.W.K
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	BMC 2020
Subjects:	cisplatin cyclooxygenase 2 fluorouracil antineoplastic agent PTGS2 protein, human adjuvant therapy adult aged article cancer chemotherapy cancer radiotherapy cancer staging cancer survival cohort analysis controlled study female human human tissue immunohistochemistry major clinical study male multiple cycle treatment nasopharynx carcinoma overall survival prognosis protein expression treatment response adolescent clinical trial comparative study enzymology metabolism middle aged multimodality cancer therapy nasopharynx tumor phase 3 clinical trial radiation dose randomized controlled trial survival rate treatment outcome Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase III as Topic Combined Modality Therapy Cyclooxygenase 2 Female Humans Male Middle Aged Nasopharyngeal Neoplasms Neoplasm Staging Prognosis Radiotherapy Dosage Randomized Controlled Trials as Topic Survival Rate Treatment Outcome Young Adult
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/178221
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-178221
record_format	dspace
spelling	sg-nus-scholar.10635-1782212023-09-07T09:11:32Z Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01) Loong, S.L.E Hwang, J.S.G Li, H.H Wee, J.T.S Yap, S.P Chua, M.L.K Fong, K.W Tan, T.W.K DUKE-NUS MEDICAL SCHOOL cisplatin cyclooxygenase 2 fluorouracil antineoplastic agent cyclooxygenase 2 PTGS2 protein, human adjuvant therapy adult aged article cancer chemotherapy cancer radiotherapy cancer staging cancer survival cohort analysis controlled study female human human tissue immunohistochemistry major clinical study male multiple cycle treatment nasopharynx carcinoma overall survival prognosis protein expression treatment response adolescent clinical trial comparative study enzymology metabolism middle aged multimodality cancer therapy nasopharynx tumor phase 3 clinical trial radiation dose randomized controlled trial survival rate treatment outcome Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase III as Topic Combined Modality Therapy Cyclooxygenase 2 Female Humans Male Middle Aged Nasopharyngeal Neoplasms Neoplasm Staging Prognosis Radiotherapy Dosage Randomized Controlled Trials as Topic Survival Rate Treatment Outcome Young Adult 10.1186/1748-717X-4-23 Radiation Oncology 4 23 2020-10-20T08:24:38Z 2020-10-20T08:24:38Z 2009 Article Loong, S.L.E, Hwang, J.S.G, Li, H.H, Wee, J.T.S, Yap, S.P, Chua, M.L.K, Fong, K.W, Tan, T.W.K (2009). Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01). Radiation Oncology 4 : 23. ScholarBank@NUS Repository. https://doi.org/10.1186/1748-717X-4-23 1748-717X https://scholarbank.nus.edu.sg/handle/10635/178221 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ BMC Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	cisplatin cyclooxygenase 2 fluorouracil antineoplastic agent cyclooxygenase 2 PTGS2 protein, human adjuvant therapy adult aged article cancer chemotherapy cancer radiotherapy cancer staging cancer survival cohort analysis controlled study female human human tissue immunohistochemistry major clinical study male multiple cycle treatment nasopharynx carcinoma overall survival prognosis protein expression treatment response adolescent clinical trial comparative study enzymology metabolism middle aged multimodality cancer therapy nasopharynx tumor phase 3 clinical trial radiation dose randomized controlled trial survival rate treatment outcome Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase III as Topic Combined Modality Therapy Cyclooxygenase 2 Female Humans Male Middle Aged Nasopharyngeal Neoplasms Neoplasm Staging Prognosis Radiotherapy Dosage Randomized Controlled Trials as Topic Survival Rate Treatment Outcome Young Adult
spellingShingle	cisplatin cyclooxygenase 2 fluorouracil antineoplastic agent cyclooxygenase 2 PTGS2 protein, human adjuvant therapy adult aged article cancer chemotherapy cancer radiotherapy cancer staging cancer survival cohort analysis controlled study female human human tissue immunohistochemistry major clinical study male multiple cycle treatment nasopharynx carcinoma overall survival prognosis protein expression treatment response adolescent clinical trial comparative study enzymology metabolism middle aged multimodality cancer therapy nasopharynx tumor phase 3 clinical trial radiation dose randomized controlled trial survival rate treatment outcome Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase III as Topic Combined Modality Therapy Cyclooxygenase 2 Female Humans Male Middle Aged Nasopharyngeal Neoplasms Neoplasm Staging Prognosis Radiotherapy Dosage Randomized Controlled Trials as Topic Survival Rate Treatment Outcome Young Adult Loong, S.L.E Hwang, J.S.G Li, H.H Wee, J.T.S Yap, S.P Chua, M.L.K Fong, K.W Tan, T.W.K Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
description	10.1186/1748-717X-4-23
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Loong, S.L.E Hwang, J.S.G Li, H.H Wee, J.T.S Yap, S.P Chua, M.L.K Fong, K.W Tan, T.W.K
format	Article
author	Loong, S.L.E Hwang, J.S.G Li, H.H Wee, J.T.S Yap, S.P Chua, M.L.K Fong, K.W Tan, T.W.K
author_sort	Loong, S.L.E
title	Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
title_short	Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
title_full	Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
title_fullStr	Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
title_full_unstemmed	Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
title_sort	weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (sqnp-01)
publisher	BMC
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/178221
_version_	1779152195571154944

Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)

Similar Items